Market closed · Next open: Tuesday 9:30 AM ET
Last update: Sep 4, 2026, 5:08 PM ET
Market closed·122 changes confirmed today

Track the stock moves that actually matter.

BestStocks detects meaningful changes across price, volume, earnings, filings, valuation, analyst revisions, and risk signals — and shows you the evidence behind each one.

1,000 equities monitored14 signal typesCross-checked against SEC EDGARMedian detection lag ~41s

Investment research built around change detection.

Showing:

BestStocks identifies what changed across companies and sectors, explains why it matters, and helps investors spot opportunities worth investigating.

Sep 4 session - Last update: Sep 4, 2026, 4:43 PM ET
TRU
TransUnion
$79.88
6.07%
Prev close $75.31
Sep 4, 2026 ET
Material / EarningsHigh confidence

What changed: TransUnion (TRU) moved +6.07% from $75.31 to $79.88 on 2026-09-04 on significantly elevated volume (2.4x the 5-day average). We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found. The move appears to reflect a reversal from earlier downward pressure tied to macroeconomic headwinds (rising oil prices, Treasury yields above 5.3%, and geopolitical tensions) that had weighed on credit-sensitive equities.

Source: daily_prices:fmp_change_percent

Changes History →
What's next

TransUnion is scheduled to report earnings on 2026-10-22 with a consensus EPS estimate of $1.21; watch for any update to guidance on consumer credit trends.

Sep 4 session - Last update: Sep 4, 2026, 4:45 PM ET
ETSY
Etsy, Inc.
$76.51
6.34%
Prev close $81.69
Sep 4, 2026 ET
🛡Material / EarningsHigh confidence

What changed: Etsy, Inc. (ETSY) moved -6.34% from $81.69 to $76.51 on September 4, 2026, reaching a new 30-day low on modestly elevated volume (1.3x the 5-day average). The decline reflects investor concerns over profitability and margins, routine insider selling by executives, and cautious positioning ahead of the Goldman Sachs Conference scheduled for September 9.

Source: daily_prices:fmp_change_percent

Changes History →
What's next

Goldman Sachs Conference on September 9, 2026, and ETSY earnings scheduled for November 4, 2026 (consensus EPS estimate $1.27).

Sep 4 session - Last update: Sep 4, 2026, 4:42 PM ET
XPO
XPO Logistics, Inc.
$193.10
5.13%
Prev close $183.68
Sep 4, 2026 ET
Material / EarningsHigh confidence

What changed: XPO Logistics, Inc. (XPO) moved +5.13% on September 4, 2026, following S&P Global Ratings' upgrade of the company's issuer credit rating to BB+ from BB. The upgrade recognized improved debt ratios and strong freight growth expectations through year-end. Institutional buyers including BlackRock also expanded positions during the period.

Source: daily_prices:fmp_change_percent

Changes History →
What's next

XPO earnings are scheduled for October 29, 2026, with a consensus EPS estimate of $1.56.

Sep 4 session - Last update: Sep 4, 2026, 4:41 PM ET
MRNA
Moderna, Inc.
$145.55
5.25%
Prev close $153.62
Sep 4, 2026 ET
🛡Material / EarningsHigh confidence

What changed: Moderna, Inc. (MRNA) moved -5.25% from $153.62 to $145.55 on 2026-09-04. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was near its 5-day average, suggesting typical trading activity.

Source: daily_prices:fmp_change_percent

Changes History →
What's next

Monitor for any news releases or SEC filings between now and the 2026-11-05 earnings announcement.

Sep 4 session - Last update: Sep 4, 2026, 4:41 PM ET
NRG
NRG Energy, Inc.
$119.02
6.95%
Prev close $111.29
Sep 4, 2026 ET
Material / EarningsHigh confidence

What changed: NRG Energy, Inc. (NRG) moved +6.95% from $111.29 to $119.02 on September 4, 2026. We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was identified. The move occurred on modestly elevated volume (1.3x the 5-day average).

Source: daily_prices:fmp_change_percent

Changes History →
What's next

NRG Energy earnings report on November 5, 2026 — monitor whether EPS and guidance suggest recovery from the Q2 2026 miss.

Sep 4 session - Last update: Sep 4, 2026, 4:42 PM ET
EFX
Equifax Inc.
$177.05
4.92%
Prev close $168.75
Sep 4, 2026 ET
Material / EarningsHigh confidence

What changed: Equifax Inc. (EFX) moved +4.92% from $168.75 to $177.05 on 2026-09-04 on elevated volume (3.3x the 5-day average). We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found. The move occurred as broader market indices fell due to profit-taking and rising Treasury yields (10-year yield above 4.2%), suggesting EFX's gain was driven by relative strength or sector rotation rather than company-specific news.

Source: daily_prices:fmp_change_percent

Changes History →
What's next

Equifax earnings release on 2026-10-20 and any updates on valuation concerns mentioned in recent legal and settlement news.

Sep 4 session - Last update: Sep 4, 2026, 5:08 PM ET
SIRI
Sirius XM Holdings Inc.
$28.99
2.62%
Prev close $29.77
Sep 4, 2026 ET
🛡Material / EarningsHigh confidence

What changed: Sirius XM Holdings Inc. (SIRI) moved -2.62% from $29.77 to $28.99 on 2026-09-04. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was near its 5-day average, suggesting routine trading.

Source: daily_prices:fmp_change_percent

Changes History →
What's next

SIRI earnings are scheduled for 2026-10-29 with a consensus EPS estimate of $0.77.

Sep 4 session - Last update: Sep 4, 2026, 5:08 PM ET
ARW
Arrow Electronics, Inc.
$215.97
3.20%
Prev close $209.28
Sep 4, 2026 ET
Material / EarningsHigh confidence

What changed: Arrow Electronics, Inc. (ARW) moved +3.20% from $209.28 to $215.97 on 2026-09-04. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average, suggesting the move was not driven by unusual trading activity.

Source: daily_prices:fmp_change_percent

Changes History →
What's next

Monitor ARW's earnings announcement on or around 2026-10-29 for any significant variance from the $4.75 EPS consensus.

Sep 4 session - Last update: Sep 4, 2026, 4:47 PM ET
NE
Noble Corporation Plc
$45.61
3.08%
Prev close $47.06
Sep 4, 2026 ET
🛡Material / EarningsHigh confidence

What changed: Noble Corporation Plc (NE) moved -3.08% from $47.06 to $45.61 on 2026-09-04. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was near its 5-day average, suggesting the decline occurred on typical trading activity.

Source: daily_prices:fmp_change_percent

Changes History →
What's next

Monitor for NE earnings on 2026-10-26 to assess whether recent price weakness was justified by fundamentals.

Sep 4 session - Last update: Sep 4, 2026, 4:46 PM ET
HNGE
Hinge Health, Inc.
$92.37
2.63%
Prev close $90.00
Sep 4, 2026 ET
Material / EarningsHigh confidence

What changed: Hinge Health, Inc. (HNGE) moved +2.63% from $90.00 to $92.37 on 2026-09-04. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was near its 5-day average, suggesting routine trading activity.

Source: daily_prices:fmp_change_percent

Changes History →
What's next

Monitor for HNGE earnings report on or around 2026-11-03 and compare actual EPS to the $0.67 consensus estimate.

Sep 4 session - Last update: Sep 4, 2026, 4:46 PM ET
AN
AutoNation, Inc.
$212.36
2.91%
Prev close $206.35
Sep 4, 2026 ET
Material / EarningsHigh confidence

What changed: AutoNation, Inc. (AN) moved +2.91% from $206.35 to $212.36 on September 4, 2026. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move occurred on volume near its 5-day average.

Source: daily_prices:fmp_change_percent

Changes History →
What's next

AutoNation's Q3 2026 earnings on October 22, 2026, where consensus EPS estimate is $5.73.

Sep 4 session - Last update: Sep 4, 2026, 4:46 PM ET
CHDN
Churchill Downs Incorporated
$87.07
2.89%
Prev close $89.66
Sep 4, 2026 ET
🛡Material / EarningsHigh confidence

What changed: Churchill Downs Incorporated (CHDN) moved -2.89% from $89.66 to $87.07 on 2026-09-04. We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found. The move occurred on below-average volume (0.6x the 5-day average).

Source: daily_prices:fmp_change_percent

Changes History →
What's next

Monitor CHDN earnings announcement on 2026-10-28 for actual results versus the $1.22 consensus estimate.

Latest research

View all research →

In-depth equity research from the BestStocks desk — earnings breakdowns, valuation deep dives, and sector analysis behind the changes we detect.

The glass-walled Apple Park ring headquarters in Cupertino, California at dusk, representing Apple's corporate leadership and its upcoming product event.
TechnologySeptember 1, 2026 · 8 min read

Apple (AAPL) Rises as Ternus Takes Over and the Sept. 9 iPhone Event Nears

Apple rose about 2.5% to roughly $325 on September 1, and the striking part was the company it kept: on a risk-off day driven by rising Treasury yields, Apple was one of the very few large-caps to rise — Meta also gained — while Microsoft, Nvidia and Alphabet slipped alongside the Nasdaq-100. The day carried two milestones. A long-planned leadership handover took effect: John Ternus, the hardware engineer behind the iPhone and Vision Pro, became CEO, with Tim Cook — chief executive since 2011 — moving to executive chairman; the succession was announced back in April, so this was the orderly handover, not fresh news. And Apple's September 9 event, expected to unveil the iPhone 18 Pro and a first foldable, is days away. The catch is valuation: at about 36 times earnings, after a ~40% run, the stock sits right at its average analyst target and about 6% below its late-July record — and the Street is split, with a Bernstein $370 bull case against a rare Jefferies bearish call (an Underperform near $264).

A large green combine harvester working through a golden field of ripe corn at harvest under a clear sky, representing Deere's agricultural-equipment business.
IndustrialsSeptember 1, 2026 · 8 min read

Deere (DE) Hits a Record High After a Baird Upgrade on a 2027 Ag Recovery

Deere rose about 2.6% to a record high near $676 on September 1, standing out on a day technology and semiconductors sold off. The catalyst was dated and company-specific: a day earlier, Baird's Mircea Dobre upgraded Deere to Outperform and raised his price target to $800 from $640, arguing North American crop economics improve in 2027 — corn back above breakeven, better soybean margins, tighter stocks-to-use. Baird upgraded AGCO the same day, and both farm-equipment makers rose while construction bellwether Caterpillar fell, isolating an agriculture-specific move rather than a broad machinery rally. The puzzle is the valuation: Deere trades at about 36 times trailing earnings, but that reflects an expected fiscal-2026 revenue trough (down ~10% on consensus estimates), with fiscal-2027 modeled up ~8% — the recovery the upgrade is betting on. The catch: after a ~40% run to a record, the Street is split, with 11 of 24 analysts at Hold and an average target just below the price.

The interior of a modern automated pharmaceutical distribution warehouse with long aisles of medicine storage and robotic handling systems, representing McKesson's drug-distribution business.
HealthcareSeptember 1, 2026 · 11 min read

McKesson (MCK) Rises as a Defensive Bid Meets a $2.25B Precision Medicine Deal

McKesson rose about 2.5% to near $907 (in the upper part of its 52-week range) on September 1, standing out as technology and semiconductors sold off. The move came amid a rotation away from technology and rate-sensitive growth, as defensive areas outperformed: with the Nasdaq-100 down more than 1%, low-beta healthcare gained, and the drug distributors were among the winners — Cardinal Health and Cencora also rose. McKesson had its own tailwinds, too. On August 25 it agreed to acquire Precision Medicine Group for about $2.25 billion, folding a clinical-research and commercialization business into its fast-growing Oncology & Multispecialty segment, and it paired that with a raised outlook and a 15% dividend increase — markers of a deliberate pivot from thin-margin drug distribution into higher-value oncology and specialty services. Even so, the stock trades at about 19 times forward earnings after growing EPS more than 50% over the past year. The catch: after a ~32% run, McKesson sits near the ~$987 average analyst target, so the valuation upside has narrowed. It is a high-quality, defensively-tilted compounder the market has already discovered.

The interior of a bright, busy off-price apparel store with long racks of discounted clothing receding into the distance, evoking Burlington's treasure-hunt retail model.
ConsumerAugust 31, 2026 · 10 min read

Burlington (BURL) Stock Falls ~5% as Q3 Outlook Overshadows Q2 Beat

Burlington Stores fell about 4.8% to around $259.76 intraday on August 31, its third straight decline since the August 27 fiscal Q2 report (down ~7.6% on the 27th and ~5.9% on the 28th). The headline looked strong — reported adjusted EPS of $2.96, roughly 35% above consensus, with margin expansion and a 15th straight quarter of double-digit EPS growth — but the market looked past it. Comparable-store sales grew just 2% (down from 5% a year earlier), revenue narrowly missed at ~$3.00 billion, and Burlington guided third-quarter margins and EPS lower as it reinvests a $55 million tariff refund into customer prices. That refund also flattered the headline beat: Burlington's cleaner adjusted EPS ex-refund was $2.37 (still +38% year over year). Even though it raised full-year EPS guidance to $11.77–$11.97, a stock at ~23x earnings could not sustain a 2% comp and softer near-term margins, and Monday's leg down came as Goldman Sachs and Deutsche Bank cut targets. The move was company-specific: off-price peers Ross Stores and TJX fell less than 1% the same day. The stock is now deeply oversold (down ~31% from its high), yet 18 analysts keep a Buy consensus and a ~$365 average target.

An abstract scientific image of a stylized human heart with a glowing electrocardiogram waveform, evoking cardiovascular drug development and clinical research.
HealthcareAugust 31, 2026 · 11 min read

Cytokinetics (CYTK) Stock Falls Despite a Positive Phase 3 Aficamten Win

Cytokinetics fell about 7.5% on Friday and another ~3% Monday (to roughly $70) even though its pivotal Phase 3 ACACIA-HCM trial of aficamten met its goals in non-obstructive hypertrophic cardiomyopathy. The full data, presented at the ESC 2026 congress, hit both primary endpoints (symptoms and exercise capacity) — but the positive topline had been known since May, the stock had nearly doubled over the year, and the details disappointed: a modest effect size, two secondary endpoints that missed significance, and reduced ejection fraction (below-50% in ~10.5% of patients versus 0.8%; a known, reversible class effect). With a supplemental FDA filing not due until Q4 2026, revenue is years off, so investors sold. CYTK underperformed a soft biotech tape. Still, the Street stayed bullish: across 22 analysts, 20 rate CYTK a buy-equivalent, with an average target near $110 (about 57% above the price). Aficamten, already sold as Myqorzo for obstructive HCM, would expand into a large new patient group if the data carries through — the debate is about the details and the timeline, not whether the drug works.

An abstract visual-discovery mood board — a grid of colorful pinned images and swatches on a wall — evoking Pinterest's image-driven social-media and advertising platform.
TechnologyAugust 31, 2026 · 10 min read

Pinterest (PINS) Stock Falls 6% After CFO Julia Donnelly Resigns

Pinterest fell about 6% to around $21.73 on August 31 after disclosing that CFO Julia Brau Donnelly is resigning to join a private, early-stage company. She will stay until October 30 for an orderly transition, with a finance executive named interim CFO and an external search underway; the company said the exit is not due to any disagreement. Still, losing a CFO whose tenure the CEO credited with 11 straight quarters of double-digit revenue growth rattled a stock already down ~41% over the past year and trading at just ~11x forward earnings. The move was company-specific: the same day, ad peers Snap and The Trade Desk actually rose, while Meta and Alphabet fell only modestly. Analysts are constructive but split — a Buy consensus with a ~$29 average target, yet a cluster of Holds near the price — leaving the CFO exit to reopen, rather than settle, the debate over whether Pinterest's growth story holds.